Sanofi Pasteur SA

Type: Company
Name: Sanofi Pasteur SA
First reported 6 hours ago - Updated 6 hours ago - 1 reports

FDA News Roundup: Astellas, Sanofi Pasteur, Orexigen, and More

By , associate editorFDA Approves IND For Non-Hodgkins Lymphoma DrugBiopharmaceutical company Molecular Templates got a nod of approval from the FDA on its Investigational New Drug (IND) application for MT-3724 last week. MT-3724 is a next-generation ... [Published Pharmaceutical Online - 6 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Dad travels the country educating parents about Meningitis vaccine

CLEVELAND, OH (WOIO) -Bob Werner travels the country spreading the word about the dangers of Meningitis, "It's crazy to think that there are other parents who might have to go through this," he said.It was ten years ago and his daughter Becky didn't feel ... [Published 19 Action News - 6 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 1 reports

China Human Vaccine Industry Report, 2014-2017

/PRNewswire/ -- Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China's human vaccine lot release volume grew by 4.9% from a year earlier, and the market size expanded 2.8% ... [Published Sacramento Bee - 7 hours ago]
Entities: Vaccine, China, Polio
First reported Sep 14 2014 - Updated Sep 14 2014 - 1 reports

FDA Approves Sanofi's Menactra Vaccine

Sanofi Pasteur, the vaccines division of Sanofi announced that the US Food and Drug Administration (FDA) approved use of Menactra [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against ... [Published PharmaAsia - Sep 14 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Study Proves the Benefit of High-Dose Influenza Vaccine in Seniors

Results of a study led by researchers at Vanderbilt University has proved the benefits of high-dose influenza vaccine in patients 65 years and older. Results of the 31,989-participant, 126-center study, published in the August 2014 issue of the The New ... [Published Pharmacy Times - Sep 12 2014]
First reported Sep 11 2014 - Updated Sep 12 2014 - 1 reports

Is the world on track for polio eradication by 2018?

Polio is a viral disease that, until the 1980s, crippled an estimated 350,000 children every year. After a global campaign for polio vaccination, in 2012, fewer than 250 children were paralysed worldwide.But the disease remains endemic in Afghanistan, ... [Published SciDev.Net - Sep 11 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Sanofi Pasteur Garners Approval by FDA for Use of Menactra Vaccine

Sanofi Pasteur reported that the U.S. Food and Drug Administration (FDA) approved use of Menactra [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal disease in persons ... [Published Individual.com - Sep 11 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Coleen Gill

, of Greentown, died Tuesday at home after a long illness.Born in Tucson, Arizona, daughter of Margaret Hunter Miller, she was of the Southern Baptist faith.She was a graduate of Pleasant Valley High School, and attended Veterinary Tech School.Prior to ... [Published Pocono Record - Sep 11 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Ovopharm to install iD equipment in new hatchery

The merger of Hubert CAIF and Ovopharm resulted in the plan to build a new Ovopharm hatchery of 4,500 square meters in Val de Reuil, France.The new hatchery is designed for the production of eggs which will guarantee production of the flu vaccine Sanofi ... [Published WorldPoultry.net - Sep 10 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

FDA approves Sanofi Pasteur's Menactra as a booster vaccine

SWIFTWATER, Pa. —  Sanofi Pasteur announced that the Food and Drug Administration approved the use of Menactra [meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine] as a booster vaccination against meningococcal ... [Published Drug Store News - Sep 09 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 7 reports

Sanofi Reports Positive Phase III Data on Dengue Vaccine

Sanofi ’s ( SNY ) vaccines division, Sanofi Pasteur, announced that a phase III efficacy study on its dengue vaccine candidate has met the primary endpoint.The randomized, observer-blind, placebo-controlled, multi-center phase III study enrolled 20,875 ... [Published Yahoo! Finance - Sep 03 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 2 reports

Research and Markets: Global Meningococcal Vaccines Market 2014-2018 - Key Vendors are GlaxoSmithKline, Novartis & Sanofi Pasteur

Research and Markets ( http://www.researchandmarkets.com/research/cb5k6l/global )has announced the addition of the "GlobalMeningococcal Vaccines Market 2014-2018" report to theiroffering.The Global Meningococcal Vaccines market to grow at a CAGR of 15% ... [Published MoneyShow.com - Sep 03 2014]

Quotes

Bob Werner travels the country spreading the word about the dangers of Meningitis, "It's crazy to think that there are other parents who might have to go through this" he said
Despite these recommendations, results from CDC "s recently published 2013 National Immunization Survey-Teen (NIS-Teen) showed that the second-dose completion rate for meningococcal conjugate vaccine was only an estimated 29.6 per cent among 17-year-olds, compared to a single-dose completion rate of 77.8 per cent among 13-through 17-year-olds."
...preventing cases of meningococcal meningitis," said David P Greenberg, M D , Vice President, U S Scientific and Medical Affairs, Sanofi Pasteur. "With this approval, we hope health care providers are reminded to talk to their teen patients and their parents about the CDC's recommendations, ultimately helping to improve booster immunization rates for teens across the country."
...The FDA laid out 24 observations, saying the "there have been no less than 58 documented non-conformances relating to the isolation of mold within the BCG aseptic processing areas" since August 2010

More Content

All (194) | News (152) | Reports (0) | Blogs (38) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
FDA News Roundup: Astellas, Sanofi Pasteur, Ore... [Published Pharmaceutical Online - 6 hours ago]
Dad travels the country educating parents about... [Published 19 Action News - 6 hours ago]
China Human Vaccine Industry Report, 2014-2017 [Published Sacramento Bee - 7 hours ago]
FDA Approves Sanofi's Menactra Vaccine [Published PharmaAsia - Sep 14 2014]
Latest flu vaccines offer protection from 4 inf... [Published Pittsburgh Tribune Review - Sep 13 2014]
Study Proves the Benefit of High-Dose Influenza... [Published Pharmacy Times - Sep 12 2014]
Adults 65 And Older Should Understand Flu-Relat... [Published Bloomer Advance - Sep 12 2014]
Is the world on track for polio eradication by ... [Published SciDev.Net - Sep 11 2014]
Canadians kept in dark about defective drugs [Published Toronto Star Online - Sep 11 2014]
Coleen Gill [Published Pocono Record - Sep 11 2014]
Sanofi Pasteur Garners Approval by FDA for Use ... [Published Individual.com - Sep 11 2014]
Merck again shipping BCG cancer treatment but S... [Published FiercePharmaManufacturing - Sep 10 2014]
Sanofi Announces $2.5 Million Contribution To D... [Published TheStreet.com - Sep 10 2014]
Sanofi Announces $2.5 Million Contribution to D... [Published TickerTech.com - Sep 10 2014]
Ovopharm to install iD equipment in new hatchery [Published WorldPoultry.net - Sep 10 2014]
Meningococcal Vaccine Gets FDA Nod for Booster ... [Published Pharmacy Times - Sep 09 2014]
The global market for human vaccines experience... [Published Live-PR.com - Sep 09 2014]
FDA approves Sanofi Pasteur's Menactra as a boo... [Published Drug Store News - Sep 09 2014]
Tetanus Therapeutics Pipeline Review, H2 2014 -... [Published Individual.com - Sep 09 2014]
Shortage of bladder cancer drug could be tragic... [Published CJAD 800 - Sep 08 2014]
FDA Approves Use of Menactra Vaccine for Booste... [Published PharmaceuticalProcessing - Sep 08 2014]
FDA Approves Use of Menactra® Vaccine for Boost... [Published U-T San Diego - Sep 08 2014]
FDA Approves Use of Menactra® Vaccine for Boost... [Published PR Newswire: Policy & Public Interest - Sep 08 2014]
Court defines 'substantial' in decision on shar... [Published Lexology - Sep 08 2014]
Canadian shortage of vital bladder cancer drug ... [Published Globe and Mail - Sep 08 2014]
City launches ‘Dak-Pa’ vs dengue [Published Sun Star Network - Sep 07 2014]
Vaccine against dengue almost available in DR [Published Dominican Today - Sep 06 2014]
A Doctor's Perspective: How to Help Protect You... [Published Huffington Post - Sep 05 2014]
Research and Markets: Global Hepatitis B Vaccin... [Published Business Wire Health News - Sep 05 2014]
Asia grapples with dengue, malaria threats [Published Nikkei Asian Review - Sep 05 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
FDA Approves Use of Menactra® Vaccine for Boost... [Published PR Newswire: Policy & Public Interest - Sep 08 2014]
SWIFTWATER, Pa., Sept. 8, 2014 /PRNewswire-USNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) approved use of Menactra® [Meningococcal (Groups ...
Research and Markets: Global Hepatitis B Vaccin... [Published Business Wire Health News - Sep 05 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6bmnvq/global_hepatitis) has announced the addition of the "Global Hepatitis B Vaccines Market 2014-2018" report to their offering. The Global Hepatitis B Vaccines ...
World: More Good News for the Fight against Den... [Published ReliefWeb - Latest Updates - Sep 05 2014]
Source: Bill & Melinda Gates FoundationCountry: World LANCE GORDON September 04, 2014 The fight against dengue fever received a tremendous boost yesterday, as Sanofi Pasteur announced pivotal results from the final Phase III trial of its candidate dengue ...
Research and Markets: Global Meningococcal Vacc... [Published Business Wire Health News - Sep 03 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cb5k6l/global) has announced the addition of the "Global Meningococcal Vaccines Market 2014-2018" report to their offering. The Global Meningococcal Vaccines market ...
Sanofi Pasteur Announces Publication of Positiv... [Published PR Newswire: Health - Aug 13 2014]
LYON, France, Aug. 13, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy ...
1 2 3 4 5 6 7 8

Press Releases

sort by: Date | Relevance
Sanofi Pasteur’s Dengue Vaccine Candidate Succe... [Published Sanofi.com - Last press releases - Sep 03 2014]
Sanofi Pasteur Announces Publication of Positiv... [Published Sanofi.com - Last press releases - Aug 13 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.